Last 12 months
Inside the activity.
1 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 18:56 UTC |
Okun Philip ADirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000018 · primary_doc.xml · nonDerivative · entry 1 Okun Philip A · CIK 0001912997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,445 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of March 1, 2025, March 1, 2026, March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:49 UTC |
Abraham VarkeyDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000017 · primary_doc.xml · nonDerivative · entry 1 Abraham Varkey · CIK 0001910368 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,529 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of March 1, 2025, March 1, 2026, March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:21 UTC |
Sisti ElenaDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000015 · primary_doc.xml · nonDerivative · entry 1 Sisti Elena · CIK 0001913271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,878 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of March 1, 2025, March 1, 2026, March 1, 2027, March 1, 2028, and March 1, 2029. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:14 UTC |
Katz Michael David M.D.Director
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000014 · primary_doc.xml · nonDerivative · entry 1 Katz Michael David M.D. · CIK 0001919798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,222 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of March 1, 2025, March 1, 2026, March 1, 2027, March 1, 2028, and March 1, 2029 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 17:32 UTC |
Diiorio Lisa AFSVP & Chief Accounting Off.
|
Tax withholdingCommon Stock | 428 | $17.60 | $7,532.80 |
DisclosureSEC source: 0001619964-24-000009 · primary_doc.xml · nonDerivative · entry 1 Diiorio Lisa A · CIK 0001910412 · FSVP & Chief Accounting Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,891 F1 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:10 UTC |
Burke Lance PEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 187 | $17.60 | $3,291.20 |
DisclosureSEC source: 0001619964-24-000011 · primary_doc.xml · nonDerivative · entry 2 Burke Lance P · CIK 0001910427 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,971 F2 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:10 UTC |
Burke Lance PEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 853 | $17.60 | $15,012.80 |
DisclosureSEC source: 0001619964-24-000011 · primary_doc.xml · nonDerivative · entry 1 Burke Lance P · CIK 0001910427 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,158 F1 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 20:23 UTC |
Wilcox McClelland WPresident
|
Tax withholdingCommon Stock | 532 | $17.60 | $9,363.20 |
DisclosureSEC source: 0001619964-24-000010 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,087 F2 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 20:23 UTC |
Wilcox McClelland WPresident
|
Tax withholdingCommon Stock | 2,442 | $17.60 | $42,979.20 |
DisclosureSEC source: 0001619964-24-000010 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,619 F1 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:06 UTC |
Golden RobertDirector
|
PurchaseCommon Stock | 500 | $18.00 | $9,000.00 |
DisclosureSEC source: 0001619964-24-000008 · primary_doc.xml · nonDerivative · entry 1 Golden Robert · CIK 0001362517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,728 Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 21:08 UTC |
Katz Michael David M.D.Director
|
PurchaseCommon Stock | 700 | $18.02 | $12,614.00 |
DisclosureSEC source: 0001619964-24-000006 · primary_doc.xml · nonDerivative · entry 1 Katz Michael David M.D. · CIK 0001919798 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,105 Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 20:07 UTC |
Sisti ElenaDirector
|
PurchaseCommon Stock | 2,750 | $18.01 | $49,527.50 |
DisclosureSEC source: 0001619964-24-000007 · primary_doc.xml · nonDerivative · entry 1 Sisti Elena · CIK 0001913271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,761 Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:34 UTC |
Diiorio Lisa AFSVP& Chief Accounting Officer
|
GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000005 · primary_doc.xml · nonDerivative · entry 1 Diiorio Lisa A · CIK 0001910412 · FSVP& Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,319 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 11:21 UTC |
PUORRO MICHAEL PDirector · Chairman & CEO
|
GrantCommon Stock | 11,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000001 · primary_doc.xml · nonDerivative · entry 1 PUORRO MICHAEL P · CIK 0001230130 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,288 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:31 UTC |
Burke Lance PEVP & Chief Financial Officer
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000004 · primary_doc.xml · nonDerivative · entry 1 Burke Lance P · CIK 0001910427 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,011 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:27 UTC |
Corbett KevinEVP & Chief Credit Officer
|
GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000003 · primary_doc.xml · nonDerivative · entry 1 Corbett Kevin · CIK 0001919780 · EVP & Chief Credit Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,628 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029 Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:24 UTC |
Wilcox McClelland WPresident
|
GrantCommon Stock | 7,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000002 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,061 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC |
Wilcox McClelland WPresident
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 29,900 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · derivative · entry 3 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,900 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC |
Wilcox McClelland WPresident
|
Tax withholdingCommon Stock | 18,783 | $17.40 | $326,824.20 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,316 Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC |
Wilcox McClelland WPresident
|
Exercise / conversionCommon Stock | 29,900 | $4.46 | $133,354.00 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 18:59 UTC |
Okun Philip ADirector
|
SaleCommon Stock | 1,124 | $17.75 | $19,954.37 |
DisclosureSEC source: 0001619964-23-000026 · primary_doc.xml · nonDerivative · entry 1 Okun Philip A · CIK 0001912997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,328 Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 15:44 UTC |
Sorrenti John RDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 3,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000025 · primary_doc.xml · derivative · entry 2 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2024-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 15:44 UTC |
Sorrenti John RDirector
|
Exercise / conversionCommon Stock | 3,500 | $10.00 | $35,000.00 |
DisclosureSEC source: 0001619964-23-000025 · primary_doc.xml · nonDerivative · entry 1 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 12:56 UTC |
Burns Joseph FEVP & Chief Lending Officer
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000023 · primary_doc.xml · nonDerivative · entry 1 Burns Joseph F · CIK 0002001897 · EVP & Chief Lending Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of December 1, 2024, December 1, 2025, December 1, 2026, December 1, 2027 and December 1, 2028. Read SEC document |
| December 01, 2023 Filed Dec 1, 2023 17:59 UTC |
Vivona John PFSVP & Chief Risk Officer
|
GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000024 · primary_doc.xml · nonDerivative · entry 1 Vivona John P · CIK 0001998966 · FSVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of December 1, 2024, December 1, 2025, December 1, 2026, December 1, 2027 and December 1, 2028. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 17:33 UTC |
Sisti ElenaDirector
|
PurchaseCommon Stock | 265 | $18.00 | $4,770.00 |
DisclosureSEC source: 0001619964-23-000021 · primary_doc.xml · nonDerivative · entry 1 Sisti Elena · CIK 0001913271 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,011 Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 20:36 UTC |
Diiorio Lisa AFSVP & C. Accounting Officer
|
Tax withholdingCommon Stock | 428 | $19.56 | $8,371.68 |
DisclosureSEC source: 0001619964-23-000016 · primary_doc.xml · nonDerivative · entry 1 Diiorio Lisa A · CIK 0001910412 · FSVP & C. Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,319 F1 · shares: Reflects the tax withholding on February 20, 2023 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 02:29 UTC |
Wilcox McClelland WSEVP, C.Lending & Revenue Off.
|
Tax withholdingCommon Stock | 842 | $19.56 | $16,469.52 |
DisclosureSEC source: 0001619964-23-000018 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · SEVP, C.Lending & Revenue Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,199 F1 · shares: Reflects tax withholding on February 20, 2023 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 20:40 UTC |
Rouse Alice TEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 833 | $19.56 | $16,293.48 |
DisclosureSEC source: 0001619964-23-000017 · primary_doc.xml · nonDerivative · entry 1 Rouse Alice T · CIK 0001912994 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,807 F1 · shares: Reflects tax withholding on February 20, 2023 with respect to restricted shares vested on the same date, pursuant to two grants of restricted stock, each on January 27, 2022. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 16:13 UTC |
Sorrenti John RDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000015 · primary_doc.xml · nonDerivative · entry 1 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,669 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:15 UTC |
Golden RobertDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000005 · primary_doc.xml · nonDerivative · entry 1 Golden Robert · CIK 0001362517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,228 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 15:38 UTC |
Haspel Ahron HDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000010 · primary_doc.xml · nonDerivative · entry 1 Haspel Ahron H · CIK 0001355729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,506 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 14:24 UTC |
PUORRO MICHAEL PDirector · Chairman & CEO
|
GrantCommon Stock | 9,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000002 · primary_doc.xml · nonDerivative · entry 1 PUORRO MICHAEL P · CIK 0001230130 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,988 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:11 UTC |
Sisti ElenaDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000014 · primary_doc.xml · nonDerivative · entry 1 Sisti Elena · CIK 0001913271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,746 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. F2 · balance_after: Previous reports included 51,018 shares held by the reporting person's spouse as directly held, which are now reflected as indirectly held. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:07 UTC |
Okun Philip ADirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000013 · primary_doc.xml · nonDerivative · entry 1 Okun Philip A · CIK 0001912997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,452 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:02 UTC |
Negrin MetinDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000012 · primary_doc.xml · nonDerivative · entry 1 Negrin Metin · CIK 0001913177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,607 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:59 UTC |
Katz Michael David M.D.Director
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000011 · primary_doc.xml · nonDerivative · entry 1 Katz Michael David M.D. · CIK 0001919798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,405 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:30 UTC |
Abraham VarkeyDirector
|
GrantCommon Stock | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000009 · primary_doc.xml · nonDerivative · entry 1 Abraham Varkey · CIK 0001910368 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,412 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. F2 · balance_after: Previous reports included 13,334 shares held by the reporting person's spouse as directly held, which are now reflected as indirectly held. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:22 UTC |
Corbett KevinEVP & Chief Credit Officer
|
GrantCommon Stock | 2,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000007 · primary_doc.xml · nonDerivative · entry 1 Corbett Kevin · CIK 0001919780 · EVP & Chief Credit Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,818 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:25 UTC |
Rouse Alice TEVP & Chief Risk Officer
|
GrantCommon Stock | 2,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000008 · primary_doc.xml · nonDerivative · entry 1 Rouse Alice T · CIK 0001912994 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,640 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 20:18 UTC |
Burke Lance PEVP & Chief Financial Officer
|
GrantCommon Stock | 2,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000006 · primary_doc.xml · nonDerivative · entry 1 Burke Lance P · CIK 0001910427 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,201 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 19:28 UTC |
Wilcox McClelland WSEVP, C.Lending & Revenue Off.
|
GrantCommon Stock | 6,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000003 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · SEVP, C.Lending & Revenue Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,041 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:36 UTC |
Sorrenti John RDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 3,557 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001619964-22-000036 · primary_doc.xml · derivative · entry 2 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,557 shares Expires 2024-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 21:36 UTC |
Sorrenti John RDirector
|
Exercise / conversionCommon Stock | 3,557 | $10.00 | $35,570.00 |
DisclosureSEC source: 0001619964-22-000036 · primary_doc.xml · nonDerivative · entry 1 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 19:48 UTC |
Katz Michael David M.D.Director
|
PurchaseCommon Stock | 40 | $20.11 | $804.40 |
DisclosureSEC source: 0001619964-22-000033 · primary_doc.xml · nonDerivative · entry 2 Katz Michael David M.D. · CIK 0001919798 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1 Disclosed balance after: 65 F1 · ownership.nature: Held as custodian for Dr. Katz's grandchild Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 19:48 UTC |
Katz Michael David M.D.Director
|
PurchaseCommon Stock | 25 | $19.99 | $499.73 |
DisclosureSEC source: 0001619964-22-000033 · primary_doc.xml · nonDerivative · entry 1 Katz Michael David M.D. · CIK 0001919798 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1 Disclosed balance after: 25 F1 · ownership.nature: Held as custodian for Dr. Katz's grandchild Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 17:24 UTC |
Sisti ElenaDirector
|
OtherCommon Stock | 3,384 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001619964-22-000032 · primary_doc.xml · nonDerivative · entry 1 Sisti Elena · CIK 0001913271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,152 F1 · shares: Shares acquired by the reporting person as consideration for the reporting person's honoring of a guaranty of a third party's defaulted loan. F1 · price: Shares acquired by the reporting person as consideration for the reporting person's honoring of a guaranty of a third party's defaulted loan. Read SEC document |
| May 11, 2022 Filed May 11, 2022 16:10 UTC |
Diiorio Lisa AFSVP & Chief Accounting Off.
|
PurchaseCommon Stock | 1,000 | $21.00 | $21,000.00 |
DisclosureSEC source: 0001619964-22-000028 · primary_doc.xml · nonDerivative · entry 1 Diiorio Lisa A · CIK 0001910412 · FSVP & Chief Accounting Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,747 Read SEC document |
| May 11, 2022 Filed May 11, 2022 11:51 UTC |
Sorrenti John RDirector
|
PurchaseCommon Stock | 2,500 | $21.00 | $52,500.00 |
DisclosureSEC source: 0001619964-22-000025 · primary_doc.xml · nonDerivative · entry 1 Sorrenti John R · CIK 0001913282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,500 Read SEC document |
| May 11, 2022 Filed May 11, 2022 15:32 UTC |
Golden RobertDirector
|
PurchaseCommon Stock | 5,000 | $21.00 | $105,000.00 |
DisclosureSEC source: 0001619964-22-000019 · primary_doc.xml · nonDerivative · entry 1 Golden Robert · CIK 0001362517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,308 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.